Jackson Creek Investment Advisors LLC Xencor Inc Transaction History

Jackson Creek Investment Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$24.62 - $32.44 $21,222 - $27,963	-862 Reduced 2.3%	36,637 $952,000
Q2 2022 Aug 04, 2022	BUY	$19.74 - $29.01 $740,230 - $1.09 Million	37,499 New	37,499 $1.08 Million
Q1 2022 May 03, 2022	SELL	$26.68 - $41.63 $721,427 - $1.13 Million	-27,040 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$33.67 - $43.44 $63,568 - $82,014	-1,888 Reduced 6.53%	27,040 $1.09 Million
Q3 2021 Nov 02, 2021	BUY	$30.65 - $35.68 $7,815 - $9,098	255 Added 0.89%	28,928 $945,000
Q2 2021 Aug 03, 2021	BUY	$34.33 - $44.68 $984,344 - $1.28 Million	28,673 New	28,673 $989,000
Q1 2021 May 27, 2021	SELL	$40.81 - $53.88 $864,396 - $1.14 Million	-21,181 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$36.63 - $47.63 $1,318 - $1,714	-36 Reduced 0.17%	21,181 $924,000
Q3 2020 Nov 09, 2020	BUY	$30.09 - $43.02 $638,419 - $912,755	21,217 New	21,217 $823,000

214

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.09B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.